Skip to content

A randomized controlled trial based on 3D-GA and sEMG analysis of tDCS combined with a lower limb rehabilitation robot for the treatment of walking dysfunction in stroke patients

A randomized controlled trial based on 3D-GA and sEMG analysis of tDCS combined with a lower limb rehabilitation robot for the treatment of walking dysfunction in stroke patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087564
Enrollment
Unknown
Registered
2024-07-30
Start date
2023-07-28
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:robot assisted gait training
experimental group:robot assisted gait training combined with Transcranial direct current stimulation

Sponsors

Zhejiang Rehabilitation Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Meet the diagnostic criteria for stroke (symptoms and signs, imaging indicators, etc.) 2: The age range is 18-80 years old, with the first onset of the disease and a course of 1-6 months after stroke; 3: patients with lower limb modified Ashworth classification = grade 2 and Brunnstrom staging = stage 2 4: Standing balance grade 2 5: Ability to walk independently under an assistive device for at least 15 meters 6: Able to understand and follow instructions 7: Stable condition

Exclusion criteria

Exclusion criteria: 1: People with severe cognitive and speech disorders who are unable to cooperate with the training 2: people with partial blindness and visual impairment 3: people with vestibular dysfunction such as vertigo and tinnitus 4: people with lower limb fracture, severe bone and joint disease, severe cardiopulmonary, hepatic, and renal disease who are unable to be trained 5: people with postural hypotension 6: people with a history of epilepsy, a metal pacemaker in their body, a metallic implant in the brain, and a skull defect who are not suitable for transcranial direct current stimulation or evaluation 7: people who are expected to fail to complete the trial and who are likely to be poorly adherent to it.

Design outcomes

Primary

MeasureTime frame
3D gait analysis;Fugl-Meyer Lower Extremity Motor Function Assessment;

Secondary

MeasureTime frame
Surface electromyography;berg balance scale;Functional amby iation category scale;Wisconsin Gait Scale;

Countries

China

Contacts

Public ContactJianer Chen

Zhejiang Rehabilitation Medical Center, Hangzhou, Zhejiang, China

chenje@zcmu.edu.cn+86 189 5807 3235

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026